sales and revenue examples, page-4

  1. 13,191 Posts.
    lightbulb Created with Sketch. 1220
    Hi Titus,
    wont be any decision until mid next year by the FDA.

    QRX in my opinion stuffed up first time around by not submitting the trial on rate of respiratory depression.

    Odd thing was it is one of MOXDUOs advantages as I see it.

    Iam still holding and am very positive considering the last 6 such submissions for similar opiates got passed on second time round.Actually 5 out 6.

    REGARDS,
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.